This study will examine behavioral and psychological outcomes of breast density notification using a 3-group randomized design comparing usual written notification to two educationally enhanced approaches.
Age range
40 Years – 74 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Knowledge of Breast Density as a Masking Factor at First Follow-up
Timeframe: Baseline (T0) to first follow-up (T1, 2 weeks to 180 days from education end)
Anxiety Short Term (Baseline T0 to First Follow-up T1)
Timeframe: Change from baseline anxiety (T0) to T1: 2 weeks to 180 days after education end
BC Risk Assessment - Survey
Timeframe: T0 (baseline) to T1 (14 to 180 days after completion of education)